Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
Status:
Recruiting
Trial end date:
2028-08-31
Target enrollment:
Participant gender:
Summary
MYE Symphony is a multicenter, open-label, Phase 1 first-in-human study to assess the safety,
tolerability, and define the RP2D of MT-302 in participants with advanced epithelial cancer.